Bringing the fundamentals into focus…
Back to Revolution Medicines, Inc.
How Revolution Medicines, Inc. stacks up
RVMD · against 70 other Healthcare companies of similar size
Profitability
14/ 100
Near the bottom of its peers.
Ranked #68 of 71 · scores higher than 1% of peers
Bars: peers in each 10-point band of the profitability score3 peers with a profitability score of 10–19, including RVMD · Click a bar to see the companies
Why profitability scores 14?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 91% of peers. Return on assets: -40.9% vs peer median 1.7%
- a lower return on invested capital: weaker than 91% of peers. Return on invested capital: -71.8% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = RVMD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RVMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 67 reported | -71.8% | 11.5% | 3% | 33% | |
| Operating marginHigher is better · 69 reported | Not reported | 19.8% | — | — | 33% |
| Return on assetsHigher is better · 68 reported | -40.9% | 6.6% | 1% | 33% | |
| Return on equityHigher is better · 64 reported | -79.1% | 13.2% | 2% | Context only | |
| Gross marginHigher is better · 71 reported | 0.0% | 57.2% | 0% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around RVMD| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 11.26T JPY (≈$76.6B) | 99 | 72 | |
| 1 | 52.9B USD | 99 | 57 | |
| 3 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 3 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 66 | 56.0B USD | 26 | 39 | |
| 67 | 21.8B USD | 24 | 32 | |
| 68 | 23.5B USD | 14 | 27 | |
| 68 | 22.8B USD | 14 | 38 | |
| 68 | 41.6B USD | 14 | 34 | |
| 71 | 26.0B USD | 6 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score